# Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/codon-specific-kras-mutations-predict-survival-benefit-of-trifluridine-tipiracil/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joris van de Haar,Xuhui Ma,Salo Ooft,Pim W. van der Helm,Louisa R. Hoes,Sara Mainardi,David J. Pinato,Kristi Sun,Lisa Salvatore,Giampaolo Tortora,Ina Valeria Zurlo,Silvana Leo,Riccardo Giampieri,Rossana Berardi,Fabio Gelsomino,Valeria Merz,Federica Mazzuca,Lorenzo Antonuzzo,Gerardo Rosati,Chara Stavraka,Paul J. Ross,Maria Grazia Rodriquenz,Michele Pavarana,Carlo Messina,Timothy Iveson,Federica Zoratto,Anne Thomas,Elisabetta Fenocchio,Margherita Ratti,Ilaria Depetris,Massimiliano Cergnul,Cristina Morelli,Michela Libertini,Alessandro Parisi,Michele De Tursi,N. Zanaletti,Ornella Garrone,Janet Graham,Raffaella Longarini,Stefania Gobba,Angelica Petrillo,Emiliano Tamburini,Nicla La Verde,Fausto Petrelli,Vincenzo Ricci,Lodewyk F.A. Wessels,Michele Ghidini,Alessio Cortellini,Emile E. Voest,Nicola Valeri |
| Citations | 84 |
| DOI | 10.1038/s41591-023-02240-8 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41591-023-02240-8.pdf |
| OpenAlex ID | https://openalex.org/W4322766221 |
| PMID | 36864254 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Gerardo Rosati](https://scholariq.org/researchers/gerardo-rosati/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.